GLP-1 drugs like Ozempic and Wegovy have garnered consumer attention for their ability to curb unhealthy food and beverage cravings, leading to weight loss, as large CPG companies and major retailers might be able to use the moment to refocus on providing...
A recent warning letter that focused in part on gut health claims points out the chinks in FDA’s policy facade, as it takes the target firm to task over some claims that seem benign in nature.
Biohm Health, a company founded on the science relating to the importance of the fungal components of the gut microbiome, now has a testing tool that consumers can use to do their own assessments.
The use of postbiotics could be an attractive alternative to prebiotics in immunocompromised children and adults, according to a recent review. But the lack of a definition of the term is still a complicating factor in determining effectiveness, the...